AI Drives Nearly Half of 2025 Healthcare Investment, First Citizens BancShares Reports

Reuters
01/08
AI Drives Nearly Half of 2025 Healthcare Investment, <a href="https://laohu8.com/S/FCNCB">First Citizens BancShares</a> Reports

First Citizens BancShares Inc., through its Silicon Valley Bank division, released its 17th Healthcare Investments and Exits Report, highlighting significant trends in the healthcare investment landscape for 2025. The report reveals that artificial intelligence $(AI)$ companies accounted for 46% of total healthcare investment, with more than $18 billion directed to AI in the sector. Despite this surge in AI funding, overall healthcare investment declined to $46.8 billion in 2025, a 12% decrease from the previous year. The analysis notes growth in healthtech and medical device investments, while biopharma and diagnostics/tools sectors experienced declines. Large deals over $300 million represented 40% of total healthcare AI spending, the highest on record. The report also indicates a more selective venture capital environment, with total VC deals down 7% and healthcare-focused VCs raising $7 billion in new funds, significantly below the 2021 peak. The findings suggest a more concentrated and disciplined approach to healthcare investing, with capital increasingly directed toward companies demonstrating clinical validation and revenue traction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. First Citizens BancShares Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF59125) on January 08, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10